BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND TCL1A, P56279, 8115, ENSG00000100721, TCL1 AND Treatment
6 results:

  • 1. Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
    Shang T; Jiang T; Lu T; Wang H; Cui X; Pan Y; Xu M; Pei M; Ding Z; Feng X; Lin Y; Li X; Tan Y; Feng F; Dong H; Wang H; Dong L
    Front Immunol; 2023; 14():1166497. PubMed ID: 37234171
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Delineation of clinical course, outcomes, and prognostic factors in patients with T-cell prolymphocytic leukemia.
    Rose A; Zhang L; Jain AG; Poovathukaran Babu A; Sokol L; Saeed H; Mo Q; Fan W; Zhang X
    Am J Hematol; 2023 Jun; 98(6):913-921. PubMed ID: 36964941
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model.
    Severin F; Urbani A; Varanita T; Bachmann M; Azzolini M; Martini V; Pizzi M; Tos APD; Frezzato F; Mattarei A; Ghia P; Bertilaccio MTS; Gulbins E; Paradisi C; Zoratti M; Semenzato GC; Leanza L; Trentin L; Szabò I
    J Exp Clin Cancer Res; 2022 Feb; 41(1):64. PubMed ID: 35172855
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia.
    Gutjahr JC; Szenes E; Tschech L; Asslaber D; Schlederer M; Roos S; Yu X; Girbl T; Sternberg C; Egle A; Aberger F; Alon R; Kenner L; Greil R; Orian-Rousseau V; Hartmann TN
    Blood; 2018 Mar; 131(12):1337-1349. PubMed ID: 29352038
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway.
    Wang XQ; Ongkeko WM; Chen L; Yang ZF; Lu P; Chen KK; Lopez JP; Poon RT; Fan ST
    Hepatology; 2010 Aug; 52(2):528-39. PubMed ID: 20683952
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Short-term tumor cell lines from breast cancer for use as autologous tumor cell vaccines in the treatment of breast cancer.
    Dillman RO; Beutel LD; De Leon C; Nayak SK
    Cancer Biother Radiopharm; 2001 Jun; 16(3):205-11. PubMed ID: 11471485
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.